DIARYLISOXAZOLIN-VERBINDUNG
European patent · EP3218369 · In force
Register entry
- Publication number
- EP3218369
- Application number
- EP15797744
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 6, 2015
- Published
- Sep 20, 2017
- Granted
- Dec 12, 2018
- Protection ends at the latest
- Nov 5, 2035
- Next annual fee due
- Nov 30, 2026
- IPC classes
- C07D 413/04 (2006.01)A01N 43/80 (2006.01)A01P 17/00 (2006.01)
- Priority
- EP 14192483 10.11.2014
- PCT application
- PCT/US2015/059371 06.11.2015
- PCT publication
- WO2016/077158 19.05.2016
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- Dec 20, 2023
Address changed
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 20.12.2023
- Dec 1, 2023
Change
Published in Swissreg on 01.12.2023
- Dec 1, 2022
Change
Published in Swissreg on 01.12.2022
- Dec 31, 2020
Pledge entered
- Pledgee
- Goldman Sachs Bank USA, 200 West Street, New York, NY 10282, USA
Published in Swissreg on 31.12.2020
- Apr 9, 2020
Agent entered
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in Swissreg on 09.04.2020
- Dec 19, 2018
Granted
Published in Swissreg on 19.12.2018
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.